Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters

Country/Region as subject
Publication year range
1.
BMC Pediatr ; 24(1): 302, 2024 May 04.
Article in English | MEDLINE | ID: mdl-38704564

ABSTRACT

BACKGROUND: Child abuse and neglect (CAN) causes enormous suffering for those affected. OBJECTIVE: The study investigated the current state of knowledge concerning the recognition of CAN and protocols for suspected cases amongst physicians and teachers. METHODS: In a pilot study conducted in Mecklenburg-Western Pomerania from May 2020 to June 2021, we invited teachers and physicians working with children to complete an online questionnaire containing mainly multiple-choice-questions. RESULTS: In total, 45 physicians and 57 teachers responded. Altogether, 84% of physicians and 44% of teachers were aware of cases in which CAN had occurred in the context of their professional activity. Further, 31% of physicians and 23% of teachers stated that specific instructions on CAN did not exist in their professional institution or that they were not aware of them. All physicians and 98% of teachers were in favor of mandatory training on CAN for pediatric residents and trainee teachers. Although 13% of physicians and 49% of teachers considered a discussion of a suspected case of CAN to constitute a breach of confidentiality, 87% of physicians and 60% of teachers stated that they would discuss a suspected case with colleagues. CONCLUSION: Despite the fact that a large proportion of respondents had already been confronted with suspected cases of CAN, further guidelines for reporting procedures and training seem necessary. There is still uncertainty in both professions on dealing with cases of suspected CAN.


Subject(s)
Child Abuse , Physicians , School Teachers , Humans , Child Abuse/diagnosis , Child , Pilot Projects , Surveys and Questionnaires , Female , Male , Adult , Health Knowledge, Attitudes, Practice , Germany , Middle Aged , Mandatory Reporting , Attitude of Health Personnel
2.
Epilepsy Behav ; 148: 109459, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37806289

ABSTRACT

PROBLEM: Experiencing a child's seizure can be challenging for parents. METHODS: We investigated parental experiences of their child's first seizure and how their perception and management of seizures changed over time. From September 2020 to March 2021, we invited parents who had witnessed at least two of their child's seizures to take part in a semi-structured interview. Parents whose children experienced solely absence seizures were excluded. RESULTS: Of the parents, 52/74 (70%) did not recognize their child's first epileptic seizure and assumed the event to be due to a different cause, for instance teething. Parents overwhelmingly reported fear (48/74; 65%) and surprise (13/74; 18%) as the predominant emotional responses to the first seizure. In response to the most recently observed seizure parents reported feelings related to fear (33/74; 45%) and happiness (16/74; 22%), with regard to the latter, especially "being calm" or "feeling safe". Asked for thoughts in response to the first seizure, 22/74 (30%) reported concerns about their child's future, with regard to the most recent seizure, 15/74 (20%) expressed such thoughts. Of the parents, 53/74 (72%) did not know how to respond to the first seizure. Concerning the most recent seizure, 48/74 (65%) said they felt confident in managing the seizure. CONCLUSION: Experiencing the child's first seizure was very challenging for parents. During the course of the epilepsy, changes were observed in both parental perception of and confidence in managing the seizures. Physicians should consider these changes when counselling parents in order to better target their evolving needs.


Subject(s)
Epilepsy, Absence , Seizures , Humans , Child , Emotions , Parent-Child Relations , Parents/psychology
3.
Pharmazie ; 73(10): 605-608, 2018 10 01.
Article in English | MEDLINE | ID: mdl-30223926

ABSTRACT

Drug incompatibilities can lead to loss of effectiveness of drugs or to increased risk for undesirable effects that can even be life-threatening. Especially children are at high risk. Databases are an important source of information in routine care to avoid incompatibilities. However, they were supposedly developed considering drugs for use in adults. Thus, we analysed to what extent databases are appropriate for the identification of incompatibilities in intravenous (i.v.) drug therapy in paediatric intensive care. We analysed the information provided by two databases (Database A and B) on all pairs of two drugs prescribed to be administered via the same i.v. access line in a university paediatric intensive care unit during the study period of 50 days. A total of 50 different i.v. drugs was prescribed in 318 different combinations (drug pairs). We found information on (in)compatibilities in 23.0 % (73/318) in Database A and in 31.1 % (99/318) in Database B. Only in 11.0 % (35/318) of the drug pairs, both databases provided information. Considering those drug pairs, in 17.1 % (6/35) Database B indicated compatibility whereas Database A indicated incompatibility. Compatibility information delivered by databases on drugs used in paediatric intensive care is incomplete, heterogeneous, and partly contradictory. Thus, an increased awareness on the strengths and limitations of different databases is necessary to avoid patient harm.


Subject(s)
Drug Incompatibility , Intensive Care Units, Pediatric/standards , Adolescent , Child , Child, Preschool , Databases, Factual , Drug Information Services , Drug Therapy, Combination , Humans , Infant , Infant, Newborn , Infusions, Intravenous , Young Adult
4.
Klin Padiatr ; 227(2): 84-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25419720

ABSTRACT

BACKGROUND: After a first afebrile seizure, EEG in addition to cMRI is recommended for pediatric patients. Once indications requiring immediate treatment are excluded, it is of interest to determine if the results provide a prognostic tool for seizure relapses. METHODS: Patients aged between 1 month and 18 years who had a first afebrile seizure between 2006 and 2008 were retrospectively studied and monitored for another 48 months. RESULTS: Out of 248 patients, 62.5% had generalized and 36.3% focal seizures. 34.7% of the EEG results were pathological. 176 patients had a cMRI that showed in 23.3% probable epileptogenic lesions. 3 patients with benign cerebral tumours needed surgical therapy. In the following 48 months 29.4% of the children showed seizure relapses. There was a correlation between epileptic patterns in the EEG and further seizures (p=0.0001). However, the sensitivity of the EEG based diagnoses was 0.6, the specificity 0.78 and the positive predictive value 0.52. There was no correlation between epileptogenic lesions and the probability of seizure relapses. The sensitivity of the cMRI to this effect was 0.36, the specificity 0.74 and the positive predictive value 0.34. DISCUSSION: The EEG is superior to cMRI for predicting seizure relapses. The percentage of noticeable cMRI findings is high but this has low therapeutic relevance and is assumed to largely represent "incidental findings". It is important to question the value of MRI investigations for sedated small children except in the case of emergencies. The key question is whether the cMRI should be deployed to diagnose epilepsy, the probability of seizure recurrences or to classify the entity of a most likely epilepsy.


Subject(s)
Brain Diseases/diagnosis , Brain Diseases/physiopathology , Brain Neoplasms/diagnosis , Brain Neoplasms/physiopathology , Brain/pathology , Brain/physiopathology , Electroencephalography , Epilepsy/diagnosis , Epilepsy/physiopathology , Magnetic Resonance Imaging , Seizures/etiology , Adolescent , Child , Child, Preschool , Female , Humans , Incidental Findings , Infant , Male , Predictive Value of Tests , Recurrence , Retrospective Studies , Risk Assessment
5.
Klin Padiatr ; 226(2): 62-7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24687610

ABSTRACT

BACKGROUND: Drug handling in paediatric intensive care units (PICU) is prone to medication errors. We aimed to identify type and prevalence of those errors and to assess preventative interventions. METHODS: Prospective intervention study investigating a 3-step intervention for preventing errors in drug handling in a 10-bed PICU of a university hospital. Nurses' drug handling was monitored in daily routine to identify the number of patients affected by errors and overall prevalence and types of errors in drug handling. We implemented a comprehensive intervention consisting of an information handout, a training course, and a 76-page reference book tailored to reduce the prevalence. RESULTS: The prevalence of errors in drug handling decreased from 83 % (555 errors/668 processes)to 63 % (554/883; p < 0.001) after the intervention. The number of affected patients remained unchanged (95 % vs. 89 %, p = 0.370).Peroral (PO) drugs (1.33 errors/process) were more error-prone than intravenous (IV) drugs(0.64), despite being used less frequently (27 % vs.73 % of all processes, p < 0.001). The interventions decreased the prevalence to 0.77 errors/process(p < 0.001) in PO and to 0.52 in IV drugs (p = 0.025). CONCLUSION: Errors in drug handling were alarmingly frequent. PO drugs were frequently subject to errors, even though being used less frequently. The implementation of a comprehensive intervention succeeded in reducing the prevalence of errors. Yet further refinements are necessary to decrease also the number of affected patients.


Subject(s)
Critical Care Nursing/methods , Intensive Care Units, Pediatric , Medication Errors/prevention & control , Medication Systems, Hospital/organization & administration , Administration, Oral , Child , Critical Care Nursing/education , Critical Care Nursing/organization & administration , Critical Care Nursing/statistics & numerical data , Cross-Sectional Studies , Hospitals, Pediatric/organization & administration , Hospitals, Pediatric/statistics & numerical data , Hospitals, University/organization & administration , Hospitals, University/statistics & numerical data , Humans , Infusions, Intravenous/nursing , Infusions, Intravenous/statistics & numerical data , Inservice Training , Intensive Care Units, Pediatric/statistics & numerical data , Medication Errors/statistics & numerical data , Medication Systems, Hospital/statistics & numerical data , Prospective Studies , Surveys and Questionnaires
6.
Fortschr Neurol Psychiatr ; 82(1): 39-42, 2014 Jan.
Article in German | MEDLINE | ID: mdl-24446117

ABSTRACT

BACKGROUND: The prevalence of chronic headaches in children and adolescents is up to 2 % resulting in the beginning of the later typical headache careers of adults. The therapy for chronic migraine with botulinum toxin is now established in adults. However, there is only limited experience in the use of botulinum toxin in paediatric patients. METHODS: 10 patients aged 13 - 17 years who suffered from chronic migraine according to the IHS criteria were injected at 31 specific injection points of the head and neck muscles with a total amount of 150 IE of botulinum toxin A (Botox®) according to the approved scheme. The number of headache days per month over the following 9 months was recorded and side effects were retrospectively determined. RESULTS: The responder rate (that is reduction of headache days per month more than 50 %) was 7/10 at three months after the injection. On average the number of headache days per month was reduced from 19.2 days to a minimum of 10.1 days. After three to six months the number of headache days increased again in all responders. Slight local side effects such as redness or temporary pain were observed in all patients, but severe side effects such as infections, fever, ptosis or allergic reactions did not occur. DISCUSSION: This small case series shows that the therapy for chronic migraine with botulinum toxin A can also be effective and safe in adolescents. As many adolescents still suffer from headaches later as adults a link between neuropaediatricians and neurologists is justifiable. An early botulinum toxin therapy followed by the transition of the adolescents would be helpful.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Migraine Disorders/drug therapy , Neuromuscular Agents/therapeutic use , Adolescent , Adrenergic beta-Antagonists/therapeutic use , Botulinum Toxins, Type A/administration & dosage , Botulinum Toxins, Type A/adverse effects , Chronic Disease , Female , Fructose/analogs & derivatives , Fructose/therapeutic use , Humans , Male , Metoprolol/therapeutic use , Neurology , Neuromuscular Agents/administration & dosage , Neuromuscular Agents/adverse effects , Neuroprotective Agents/therapeutic use , Pediatrics , Retrospective Studies , Topiramate , Transcutaneous Electric Nerve Stimulation , Treatment Outcome
7.
Klin Padiatr ; 225(5): 277-82, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23946090

ABSTRACT

BACKGROUND: Anticonvulsants require special consideration particularly at the interface from hospital to ambulatory care. PATIENTS AND METHOD: Observational study for 6 months with prospectively enrolled consecutive patients in a neuropediatric ward of a university hospital (age 0-<18 years) with long-term therapy of at least one anticonvulsant. Assessment of outpatient prescriptions after discharge. Parent interviews for emergency treatment for acute seizures and safety precautions. RESULTS: We identified changes of the brand in 19/82 (23%) patients caused by hospital's discharge letters (4/82; 5%) or in ambulatory care (15/82; 18%). In 37/76 (49%) of patients who were deemed to require rescue medication, no recommendation for such a medication was included in the discharge letters. 17/76 (22%) of the respective parents stated that they had no immediate access to rescue medication. Safety precautions were applicable in 44 epilepsy patients. We identified knowledge deficits in 27/44 (61%) of parents. CONCLUSION: Switching of brands after discharge was frequent. In the discharge letters, rescue medications were insufficiently recommended. Additionally, parents frequently displayed knowledge deficits in risk management.


Subject(s)
Ambulatory Care , Anticonvulsants/adverse effects , Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Patient Discharge , Adolescent , Child , Child, Preschool , Drug Substitution , Drug Therapy, Combination , Female , Health Knowledge, Attitudes, Practice , Humans , Infant , Long-Term Care , Male , Medication Adherence , Parents/education , Prospective Studies , Risk Management
8.
Epilepsy Res ; 184: 106964, 2022 08.
Article in English | MEDLINE | ID: mdl-35691219

ABSTRACT

PROBLEM: Many studies focus on knowledge and attitudes of unaffected people towards epilepsy and people with epilepsy (PWE). The perspective of PWE themselves is much less explored. METHODS: We invited PWE in Germany to answer a questionnaire on their knowledge and attitudes towards epilepsy and PWE. RESULTS: The questionnaire was completed by 230 PWE (median age: 40 years; min./max.: 19/83; 66 % female). Of PWE, 22 % thought that PWE are more helpful, and 10 % thought that PWE are friendlier than other people. Nevertheless, reservations about relationships and friendships with other PWE existed: of the participants, only 74 % would definitely go on a date with another PWE, and 90 % would definitely include another PWE they liked into their circle of friends. Swimming was judged as more dangerous for PWE than for healthy people by 71 % of PWE. Of PWE, 86 % correctly assumed it was not useful to hold a person having a seizure to the ground. Putting a solid object in the mouth was considered not useful by 85 % of PWE. Of PWE, 20 % would definitely administer an available emergency medication if another PWE had a seizure. For 67 % of PWE, certain preconditions should have to be fulfilled such as an available document with instructions. Of PWE, 11 % stated they would not administer an available emergency medication if another PWE had a seizure. CONCLUSION: Although positive attitudes of PWE towards other PWE exist, we also found some reservations calling for psychosocial support. Most PWE had sufficient knowledge about risks of certain activities and about measures to be taken during a seizure. Nevertheless, a small group of PWE showed knowledge gaps. Thus, educational support still seems essential.


Subject(s)
Epilepsy , Adult , Educational Status , Epilepsy/drug therapy , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Seizures , Surveys and Questionnaires
10.
Epilepsy Res ; 172: 106587, 2021 05.
Article in English | MEDLINE | ID: mdl-33647738

ABSTRACT

PROBLEM: Pharmacists can have a large impact on attitude, acceptance and adherence in patients with long-term conditions. They should be able to give appropriate advice. METHODS: We invited pharmacists in Mecklenburg-Vorpommern and Saxony, Germany, to complete a questionnaire mainly containing multiple-choice-questions. RESULTS: Overall, 238 pharmacists took part in the survey. 199 (84%) said they were insecure counselling people with epilepsy or had no experience at all. 205 (86%) rightly assumed a seizure can result in death. Concerning an acute seizure, administration of a rescue medication was considered as possible useful measure by 127 (53%) participants. Of the participants, 206 (87%) stated a physician should be consulted for every first afebrile seizure, 188 (79%) for every first febrile seizure. Exanthema as especially clinically relevant adverse drug event was rightly chosen for carbamazepine by 18 (8%) and for lamotrigine by 12 (5%) participants. 60 (25%) rightly chose liver toxicity for valproate. The increase of carbamazepine plasma concentration when adding erythromycin was chosen by 66 (28%) of pharmacists. 13 (5%) knew about the reduction of effectiveness of lamotrigine when adding hormonal contraceptives. For valproate, 201 (84%) stated that it is important to counsel patients concerning contraception. CONCLUSION: Pharmacists are insecure counselling people with epilepsy. Some of them would not suggest to seek medical advice for every first seizure. This can lead to reduced patient safety. The adverse drug events of valproate are well known, important adverse drug events and interactions of other anticonvulsants are less present to the pharmacists and should be regularly addressed in training courses.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Epilepsy , Anticonvulsants/adverse effects , Carbamazepine/therapeutic use , Drug-Related Side Effects and Adverse Reactions/drug therapy , Epilepsy/drug therapy , Humans , Lamotrigine/therapeutic use , Pharmacists , Seizures/drug therapy , Valproic Acid/therapeutic use
11.
Ophthalmologe ; 118(4): 383-390, 2021 Apr.
Article in German | MEDLINE | ID: mdl-32632495

ABSTRACT

Cerebral folate deficiency (CFD) results in neurological alterations and a massive degeneration of the choroid/retina if left untreated, which limit the visual field and visual acuity. This article reports the case of a female patient with CFD, who developed autistic personal characteristics prior to reaching school age and first started to speak at the age of 3 years. At the age of 6 years she was presented because of unclear reduced visual acuity in the right eye. At that time mild bilateral peripheral chorioretinal atrophy was present, which subsequently became more pronounced. Additionally, a centrally emphasized chorioretinal atrophy further developed. Visual acuity of both eyes progressively deteriorated until stagnating at 0.1 at the age of 14 years. The causal assignment of the findings of the patient was not possible for many years. Choroideremia was excluded by molecular genetic testing (CHM gene with no mutations) and gyrate atrophy was ruled out by a normal ornithine level. The existence of a mitochondrial disease was almost completely excluded by exome sequencing. After the onset of further nonocular symptoms, e.g. neuromuscular disorders, electroencephalograph (EEG) alterations and autistic disorder, intensified laboratory diagnostics were performed in the treating pediatric hospital. Finally, an extremely low level of the folic acid metabolite 5­methyltetrahydrofolate was detected in the cerebrospinal fluid (CSF) leading to the diagnosis of CFD. High-dose substitution treatment with folic acid was subsequently initiated. After excluding the presence of a pathogenic mutation of the FOLR1 gene for the cerebral folate receptor 1, a high titer blocking autoantibody against cerebral folate receptor 1 was detected as the cause.


Subject(s)
Folic Acid Deficiency , Retinal Degeneration , Adolescent , Atrophy , Child , Child, Preschool , Female , Folate Receptor 1/genetics , Folic Acid , Folic Acid Deficiency/diagnosis , Folic Acid Deficiency/drug therapy , Folic Acid Deficiency/genetics , Humans
12.
Eur J Paediatr Neurol ; 22(3): 427-433, 2018 May.
Article in English | MEDLINE | ID: mdl-29475820

ABSTRACT

BACKGROUND: The main source of knowledge on adverse drug events (ADE) are physicians' reports in controlled clinical trials. In contrast, little is known about the parents' perception of ADE of anticonvulsants their children receive. METHODS: After approval by the local ethics committee, we performed a survey in a neuropediatric outpatient clinic of a university hospital. Based on a structured questionnaire, we interviewed parents of children with current anticonvulsant treatment regarding (i) their fears about potential ADE, (ii) experienced ADE according to parents, and (iii) implications of ADE on the child's life. RESULTS: Parents of 150 patients took part in the interview. (i) 95 (63.3%) parents expressed fears concerning ADE, mostly liver injury/liver failure (33 [22%]). (ii) 129 (86%) parents reported experienced ADE, mostly sedation (65 [43.3%]) and abnormal behavior (54 [36%]). (iii) Parents reported substantial implications of ADE on the child's daily life for 84 (56%) children, and 63 (42%) parents expressed a negative impact on the child's development. CONCLUSION: We recognized a great discrepancy between those ADE that were feared and those that were experienced. Parents feared life-threatening ADE and experienced less severe ADE that nevertheless have a negative impact on the child's daily life.


Subject(s)
Anticonvulsants/adverse effects , Drug-Related Side Effects and Adverse Reactions/psychology , Parents/psychology , Child , Child, Preschool , Female , Humans , Infant , Male , Surveys and Questionnaires
13.
Epilepsy Res ; 88(2-3): 118-26, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19939631

ABSTRACT

Many epileptic syndromes develop into pharmaco-resistant forms, calling for the development of new anticonvulsant strategies. The transmitter glutamate serves a double role as excitatory transmitter and as precursor for GABA, thus interfering with glutamate uptake may therefore exert complex effects on excitation-inhibition-balance in epileptic networks. In the present study we tested the effect of two different glutamate uptake blockers on acutely induced epileptiform activity in hippocampal-entorhinal cortex slices from adult rats: dihydrokainate (DHK) which blocks predominantly glial glutamate uptake, and threo-beta-benzyloxyaspartic acid (TBOA) which blocks both glial and neuronal glutamate uptake. Three different models were used to induce epileptiform discharges: (i) increasing NMDA receptor-mediated excitation by omitting Mg(2+)-ions; (ii) blocking potassium channels by 4-aminopyridine; (iii) reducing GABA(A) receptor-mediated inhibition by penicillin. Application of DHK or TBOA markedly reduced the frequency of epileptiform discharges in CA1 in the low magnesium and the 4-AP model while pathological activity was increased in the penicillin-model. In contrast, frequency of epileptiform discharges in EC was consistently increased by DHK and TBOA. Effects of DHK were more easily reversible than those of TBOA. Thus glutamate uptake blockers exert variable effects on epileptiform activity, depending on brain region and on the mechanism of ictogenesis.


Subject(s)
Entorhinal Cortex/drug effects , Entorhinal Cortex/physiopathology , Glutamic Acid/physiology , Hippocampus/drug effects , Hippocampus/physiopathology , Neurotransmitter Uptake Inhibitors/pharmacology , 4-Aminopyridine/pharmacology , Animals , Anticonvulsants/pharmacology , Aspartic Acid/pharmacology , Electrophysiology , Excitatory Postsynaptic Potentials/drug effects , Kainic Acid/analogs & derivatives , Kainic Acid/pharmacology , Male , Neurons/drug effects , Rats , Rats, Wistar , Synaptic Transmission/drug effects
14.
Qual Saf Health Care ; 19(5): e26, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20378618

ABSTRACT

BACKGROUND: Drug administration in children is an error-prone task for nurses and parents because individual dose adjustment is often necessary, and suitable formulations for children are frequently lacking. Hence, in the absence of measures for their prevention, medication errors are likely to occur. OBJECTIVE: To assess the error prevalence in drug administration by mouth or gastric tube before and after implementing a programme for quality improvement for nurses and parents. DESIGN, SETTING AND PARTICIPANTS: Prospective, two-period cohort intervention study on a paediatric neurology ward of a university hospital where drug administration procedures of nurses and parents were consecutively monitored during the routine drug administration hours. MAIN OUTCOMES MEASURE: Prevalence of administration errors before and after implementing instructions for appropriate drug administration, and a teaching and training programme supported by information pamphlets. RESULTS: Altogether, 1164 predefined administration tasks were assessed, 675 before and 489 after the intervention. Of these, 95.7% (after the INTERVENTION: 92.6%) were performed by nurses. Errors addressed by the intervention were reduced from 261/646 tasks (40.4%) to 36/453 (7.9%, p<0.001) in nurses and from 28/29 (96.6%) to 2/36 (5.6%, p<0.001) in parents. Errors in predefined categories concerning tablet dissolution, tablet storage, oral liquids, tablet splitting, administration by gastric tube and others were all considerably less frequent after the intervention (each p<0.001). CONCLUSION: Errors of drug administration by mouth and gastric tube represent a considerable and often neglected drug-related problem in paediatric inpatients. Targeted quality-improvement programmes can substantially and rapidly reduce error prevalence. Appropriate teaching and training of both nurses and parents supported by pamphlets was a highly efficient way to reduce error prevalence.


Subject(s)
Medical Staff, Hospital/education , Medication Errors/prevention & control , Parents/education , Quality of Health Care , Administration, Oral , Adult , Child , Child, Preschool , Cohort Studies , Female , Humans , Intubation, Gastrointestinal , Male , Pilot Projects , Prospective Studies , Young Adult
16.
Soc Work ; 25(2): 94-8, 1980 Mar.
Article in English | MEDLINE | ID: mdl-10246007

ABSTRACT

Case coordination is an important social work activity with roots in the earlest objectives and functions of the profession. This article outlines the theoretical framework of case coordination and describes the tasks, skills, and knowledge essential to it.


Subject(s)
Community Health Services/organization & administration , Social Work , Interinstitutional Relations , Interprofessional Relations , Patient Care Planning/standards , United States
SELECTION OF CITATIONS
SEARCH DETAIL